Mirae Asset Global ETFs Holdings
PCRX icon

Mirae Asset Global ETFs Holdings’s Pacira BioSciences PCRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$434K Sell
19,188
-1,555
-7% -$34.6K ﹤0.01% 1954
2025
Q4 		$537K Sell
20,743
-641
-3% -$15.2K ﹤0.01% 1855
2025
Q3 		$551K Sell
21,384
-3,842
-15% -$94.4K ﹤0.01% 1824
2025
Q2 		$603K Sell
25,226
-2,016
-7% -$50.8K ﹤0.01% 1720
2025
Q1 		$677K Buy
27,242
+1,165
+4% +$27.9K ﹤0.01% 1698
2024
Q4 		$491K Buy
26,077
+794
+3% +$13.9K ﹤0.01% 1931
2024
Q3 		$381K Buy
25,283
+2,505
+11% +$42.8K ﹤0.01% 2049
2024
Q2 		$652K Buy
+22,778
New +$648K ﹤0.01% 1692

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return